We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
高シグナルの見出しのみ — マクロイベント、決算、M&A、規制。リスト記事とアナリストのクリックベイトはデフォルトでフィルタ。1時間ごとに更新。
By Sahil Pandey May 20 (Reuters) - West Pharmaceutical Services said on Wednesday it has restored operations across its sites after a cybersecurity attack earlier this month and expects the incident
PacBio teams with Blank Bio after its $7.2M seed round, using HiFi long reads to build RNA AI models from patient tumor samples.
ANGO gains momentum as NanoKnife adoption, strong Med Tech growth and positive clinical trends support its long-term outlook.
DexCom gains 5.6% after announcing plans to launch Dexcom Flex in Germany, expanding CGM access for Type 2 diabetes patients using basal insulin or oral meds.
CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.
MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.
Doximity teams with Aledade to bring AI-powered documentation and clinical search tools into physician workflows and value-based care settings.
Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for reproductive diagnostics.
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q4 results, though data security threats remain a key risk.
The company confirmed data was stolen and encrypted by the attackers.
On May 4, 2026, West Pharmaceutical Services held its annual general meeting, where shareholders voted against a proposal to require an independent board chair policy. This governance outcome comes as the company has recently delivered earnings above consensus expectations, reinforcing the influence of financial performance on investor voting behavior. Against this backdrop of robust recent earnings surprises, we'll examine how the board chair vote outcome may reshape West Pharmaceutical's...